As cell-free regenerative medicine advances globally, Hong Kong patients are increasingly interested in exosome therapy for its targeted approach to tissue repair and inflammation reduction. Domestic availability of exosome treatments remains restricted under the Department of Health's regulatory framework. Our clinic in Chiang Mai, under three hours from HKIA, offers exosome therapy with Cantonese-speaking clinical support and structured follow-up with your Hong Kong physician.
Exosome therapy uses cell-free extracellular vesicles to deliver regenerative signalling molecules directly to damaged tissue. As a cell-free biological, exosomes carry growth factors, RNA, and proteins that promote tissue repair without the complexity of live cell transplantation. Treatment involves targeted delivery of purified exosomes to affected areas, often combined with other regenerative modalities for enhanced outcomes. For a comprehensive understanding of the science, evidence, and treatment process, visit our full Exosome Therapy page.
The cell-free nature of exosome therapy appeals to Hong Kong patients who want regenerative benefits with minimal downtime and lower immunological risk compared to cell-based treatments. Treatment programmes are shorter than stem cell protocols, typically three to five days, making it practical for patients travelling from overseas. Cantonese-speaking coordination, significant cost savings compared to any limited domestic options, and structured physician follow-up make the process straightforward.
Nanoscale vesicles carrying biological signals for tissue repair.
Exosome therapy is cell-free, using signalling molecules only.
A typical exosome therapy programme takes three to five days in Chiang Mai, including initial assessment, treatment, post-procedure monitoring, and follow-up consultations. Your Cantonese-speaking coordinator will help plan your schedule.
Minimal to none.
Yes.
Yes, commonly combined with stem cell and anti-ageing protocols.
Exosome-based therapies are not registered under Hong Kong's Pharmacy and Poisons Ordinance for therapeutic use. The Department of Health has not established a regulatory pathway for exosome products, and the MCHK restricts practitioners from promoting treatments outside established guidelines, effectively making exosome therapy unavailable domestically.
The under-three-hour flight from HKIA means minimal disruption to professional schedules. Treatment can be completed in three to five days, and the significant cost savings compared to any emerging Hong Kong options make it a practical choice for busy professionals.
Yes. Our Cantonese-speaking coordinators and clinical staff ensure clear communication throughout your exosome therapy journey, from initial consultation to post-treatment follow-up.